Cost of Drug Wastage From Dose Modification and Discontinuation of Oral Anticancer Drugs.

ABSTRACT:

Importance

Oral chemotherapy is often dispensed to patients as a 1-month supply, with pill dose and package size predetermined by the drug manufacturer; thus, changing the patient dosage may waste the remaining initial drug supply. The cost of pills wasted due to dose modification and discontinuation is often unreported.

Objective

To estimate the cost of pill wastage due to dose modification and discontinuation for oral anticancer drugs that were recently approved by the US Food and Drug Administration (FDA) or that are commonly prescribed.

Design, setting, and participants

This retrospective cross-sectional economic evaluation initially identified 26 oral anticancer drugs newly approved between January 1, 2020, and August 31, 2022, from the FDA website and the top 50

SUBMITTER: Lam M 

PROVIDER: S-EPMC10360002 | biostudies-literature | 2023 Sep

REPOSITORIES: biostudies-literature